Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs

被引:0
|
作者
机构
来源
Phys Rev B | / 24卷 / 2760期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 34 条
  • [1] MUTATED K65R RECOMBINANT REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SHOWS DIMINISHED CHAIN TERMINATION IN THE PRESENCE OF 2',3'-DIDEOXYCYTIDINE 5'-TRIPHOSPHATE AND OTHER DRUGS
    GU, ZX
    ARTS, EJ
    PARNIAK, MA
    WAINBERG, MA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2760 - 2764
  • [2] Kinetics and chain termination studies performed with recombinant mutated M184V and K65R HIV reverse transcriptase
    Wainberg, MA
    Quan, Y
    Gu, Z
    Li, Z
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 5 - 5
  • [3] In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase
    Parikh, UM
    Koontz, DL
    Chu, CK
    Schinazi, RF
    Mellors, JW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1139 - 1144
  • [4] Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation
    Weber, J
    Chakraborty, B
    Weberova, J
    Miller, MD
    Quiñones-Mateu, ME
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (03) : 1395 - 1400
  • [5] The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations
    Parikh, Urvi M.
    Bacheler, Lee
    Koontz, Dianna
    Mellors, John W.
    JOURNAL OF VIROLOGY, 2006, 80 (10) : 4971 - 4977
  • [6] Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1
    Coutsinos, Dimitrios
    Invernizzi, Cedric F.
    Xu, Hongtao
    Moisi, Daniela
    Oliveira, Maureen
    Brenner, Bluma G.
    Wainberg, Mark A.
    JOURNAL OF VIROLOGY, 2009, 83 (04) : 2029 - 2033
  • [7] RESISTANCE TO 2',3'-DIDEOXYCYTIDINE CONFERRED BY A MUTATION IN CODON-65 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    ZHANG, D
    CALIENDO, AM
    ERON, JJ
    DEVORE, KM
    KAPLAN, JC
    HIRSCH, MS
    DAQUILA, RT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) : 282 - 287
  • [8] Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity
    White, KL
    Margot, NA
    Wrin, T
    Petropoulos, CJ
    Miller, MD
    Naeger, LK
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3437 - 3446
  • [9] K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE
    GU, ZX
    SALOMON, H
    CHERRINGTON, JM
    MULATO, AS
    CHEN, MS
    YARCHOAN, R
    FOLI, A
    SOGOCIO, KM
    WAINBERG, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) : 1888 - 1891
  • [10] THE K65R MUTANT REVERSE-TRANSCRIPTASE OF HIV-1 CROSS-RESISTANT TO 2',3'-DIDEOXYCYTIDINE, 2',3'-DIDEOXY-3'-THIACYTIDINE, AND 2',3'-DIDEOXYINOSINE SHOWS REDUCED SENSITIVITY TO SPECIFIC DIDEOXYNUCLEOSIDE TRIPHOSPHATE INHIBITORS IN-VITRO
    GU, ZX
    FLETCHER, RS
    ARTS, EJ
    WAINBERG, MA
    PARNIAK, MA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (45) : 28118 - 28122